SCHEMBL470013

SCHEMBL470013

CN(C)C(=O)c1ccc(-c2cnc3c(NCc4cccs4)cc(Cl)nn23)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.54
CLK4 Q9HAZ1 3/20 0.54
ALDH1A1 P00352 2/20 0.54
CYP3A4 P08684 4/20 0.53
CYP2D6 P10635 4/20 0.53
CYP2C19 P33261 4/20 0.53
HSD17B10 Q99714 3/20 0.53
KDM4E B2RXH2 1/20 0.53
ALOX15 P16050 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
MAPK1 P28482 2/20 0.52
USP2 O75604 2/20 0.51
LMNA P02545 1/20 0.51
APEX1 P27695 1/20 0.51
CASP7 P55210 1/20 0.51
MEN1 O00255 1/20 0.48
TP53 P04637 1/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL470190 0.88 TTK (0.48) FYNTTKPOLB
SCHEMBL470191 0.88 FYN (0.47) FYNTTKPOLB
SCHEMBL10279098 0.81 FYN (0.46) ALDH1A1TP53HPGDFYNPOLB
SCHEMBL10279096 0.77 FYN (0.41) FYNTTK
SCHEMBL10279097 0.76 TTK (0.51) TTK
SCHEMBL463338 0.76 TTK (0.53) FYNTTKIKBKB
SCHEMBL470001 0.75 KCNN1 (0.44) CYP1A2ALDH1A1CYP3A4CYP2D6CYP2C19
SCHEMBL1947277 0.73 FYN (0.75) FYN
SCHEMBL15559752 0.71 TTK (0.55) FYNTTK
SCHEMBL462792 0.71 ERN1 (0.43) FYNTTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014020041-A1 COMBINATIONS FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-02-06 WO claimed
US-9255100-B2 Substituted imidazopyridazines BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-02-09 US disclosed
EP-2614063-B1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER IP GMBH (DE) 2016-01-13 EP disclosed
WO-2012032031-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-15 WO disclosed